| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 49 | 2023 | 255 | 9.450 |
Why?
|
| Insulin Resistance | 29 | 2021 | 392 | 5.640 |
Why?
|
| Obesity | 33 | 2025 | 1166 | 5.150 |
Why?
|
| Insulin | 37 | 2022 | 673 | 4.850 |
Why?
|
| Lipogenesis | 12 | 2023 | 65 | 4.180 |
Why?
|
| Adipose Tissue | 21 | 2022 | 283 | 4.180 |
Why?
|
| Thermogenesis | 9 | 2023 | 116 | 3.220 |
Why?
|
| Lipolysis | 11 | 2023 | 47 | 2.870 |
Why?
|
| Signal Transduction | 34 | 2023 | 2900 | 2.870 |
Why?
|
| Adipose Tissue, White | 12 | 2020 | 86 | 2.550 |
Why?
|
| Mice | 82 | 2025 | 10291 | 2.480 |
Why?
|
| Animals | 102 | 2025 | 19650 | 2.370 |
Why?
|
| Macrophages | 14 | 2020 | 1015 | 2.190 |
Why?
|
| Energy Metabolism | 9 | 2023 | 359 | 2.190 |
Why?
|
| Adipose Tissue, Brown | 9 | 2020 | 111 | 2.040 |
Why?
|
| Adipocytes, Brown | 4 | 2021 | 45 | 2.030 |
Why?
|
| Inflammation | 16 | 2021 | 1099 | 2.000 |
Why?
|
| Intra-Abdominal Fat | 6 | 2019 | 33 | 1.910 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2022 | 635 | 1.890 |
Why?
|
| Glucose Transporter Type 4 | 16 | 2011 | 57 | 1.850 |
Why?
|
| Liver | 9 | 2024 | 795 | 1.830 |
Why?
|
| Fatty Acids | 9 | 2025 | 191 | 1.790 |
Why?
|
| Triglycerides | 8 | 2021 | 231 | 1.740 |
Why?
|
| RNA, Small Interfering | 22 | 2024 | 858 | 1.720 |
Why?
|
| Mice, Inbred C57BL | 31 | 2025 | 3231 | 1.690 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2016 | 327 | 1.650 |
Why?
|
| Lipid Metabolism | 8 | 2025 | 203 | 1.620 |
Why?
|
| Insulin-Secreting Cells | 7 | 2021 | 178 | 1.540 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2016 | 188 | 1.530 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 71 | 1.530 |
Why?
|
| Atherosclerosis | 4 | 2017 | 146 | 1.520 |
Why?
|
| Adipocytes, Beige | 3 | 2020 | 15 | 1.510 |
Why?
|
| 3T3-L1 Cells | 24 | 2016 | 83 | 1.500 |
Why?
|
| Mice, Obese | 12 | 2024 | 80 | 1.480 |
Why?
|
| Adipocytes, White | 3 | 2021 | 27 | 1.440 |
Why?
|
| Glucose Intolerance | 5 | 2021 | 88 | 1.430 |
Why?
|
| PPAR gamma | 9 | 2009 | 72 | 1.400 |
Why?
|
| Gene Silencing | 10 | 2015 | 378 | 1.300 |
Why?
|
| Pericardium | 3 | 2019 | 35 | 1.230 |
Why?
|
| Fatty Liver | 6 | 2021 | 98 | 1.230 |
Why?
|
| RNA Interference | 11 | 2013 | 590 | 1.230 |
Why?
|
| Glucose | 15 | 2019 | 445 | 1.220 |
Why?
|
| Muscle Proteins | 6 | 2004 | 111 | 1.220 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2022 | 22 | 1.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2017 | 588 | 1.170 |
Why?
|
| Monosaccharide Transport Proteins | 6 | 2004 | 43 | 1.110 |
Why?
|
| Fatty Acid Synthases | 4 | 2023 | 23 | 1.090 |
Why?
|
| Mice, Knockout | 17 | 2023 | 1994 | 1.070 |
Why?
|
| Autophagy | 3 | 2023 | 213 | 1.010 |
Why?
|
| Carrier Proteins | 8 | 2013 | 697 | 1.000 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2016 | 117 | 0.970 |
Why?
|
| Endothelial Cells | 2 | 2017 | 173 | 0.960 |
Why?
|
| Gene Expression Regulation | 12 | 2015 | 1552 | 0.930 |
Why?
|
| Cell Membrane | 10 | 2011 | 486 | 0.920 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 278 | 0.890 |
Why?
|
| Adipogenesis | 4 | 2011 | 71 | 0.870 |
Why?
|
| beta-Glucans | 2 | 2016 | 54 | 0.850 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2023 | 14 | 0.840 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 131 | 0.840 |
Why?
|
| Autophagosomes | 1 | 2023 | 12 | 0.830 |
Why?
|
| Phosphorylation | 17 | 2019 | 883 | 0.810 |
Why?
|
| Phosphoproteins | 6 | 2011 | 211 | 0.810 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2011 | 146 | 0.800 |
Why?
|
| Blood Vessels | 2 | 2014 | 62 | 0.790 |
Why?
|
| Humans | 61 | 2025 | 59389 | 0.780 |
Why?
|
| Male | 38 | 2025 | 27749 | 0.780 |
Why?
|
| Drug Delivery Systems | 4 | 2021 | 312 | 0.780 |
Why?
|
| Obesity, Morbid | 2 | 2016 | 92 | 0.770 |
Why?
|
| Catecholamines | 2 | 2022 | 29 | 0.770 |
Why?
|
| Actins | 5 | 2011 | 259 | 0.760 |
Why?
|
| Cells, Cultured | 13 | 2017 | 2092 | 0.750 |
Why?
|
| Nuclear Proteins | 7 | 2014 | 750 | 0.730 |
Why?
|
| Proteins | 5 | 2010 | 730 | 0.730 |
Why?
|
| Kupffer Cells | 3 | 2017 | 42 | 0.730 |
Why?
|
| Uncoupling Protein 1 | 7 | 2020 | 50 | 0.730 |
Why?
|
| Blood Glucose | 5 | 2017 | 461 | 0.730 |
Why?
|
| Myosins | 4 | 2008 | 110 | 0.720 |
Why?
|
| Sympathetic Nervous System | 2 | 2019 | 34 | 0.710 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 171 | 0.710 |
Why?
|
| CRISPR-Cas Systems | 2 | 2021 | 333 | 0.690 |
Why?
|
| Up-Regulation | 6 | 2020 | 365 | 0.690 |
Why?
|
| RNA | 3 | 2020 | 401 | 0.690 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.680 |
Why?
|
| Cell Differentiation | 9 | 2021 | 1304 | 0.680 |
Why?
|
| Interleukin-1beta | 5 | 2017 | 258 | 0.670 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 91 | 0.660 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 74 | 0.660 |
Why?
|
| Ion Channels | 3 | 2016 | 88 | 0.650 |
Why?
|
| Mitochondrial Proteins | 4 | 2016 | 100 | 0.640 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 274 | 0.640 |
Why?
|
| Peptide Fragments | 4 | 2016 | 400 | 0.620 |
Why?
|
| Osteopontin | 2 | 2016 | 22 | 0.620 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 303 | 0.610 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 318 | 0.610 |
Why?
|
| Endocytosis | 3 | 2004 | 149 | 0.610 |
Why?
|
| Mitochondria | 9 | 2025 | 343 | 0.600 |
Why?
|
| Biological Transport | 10 | 2008 | 288 | 0.590 |
Why?
|
| Gene Targeting | 1 | 2018 | 78 | 0.590 |
Why?
|
| Adiposity | 3 | 2018 | 74 | 0.590 |
Why?
|
| Diet, High-Fat | 5 | 2025 | 163 | 0.570 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2008 | 169 | 0.570 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 789 | 0.570 |
Why?
|
| Chylous Ascites | 1 | 2017 | 2 | 0.570 |
Why?
|
| Lymphangiogenesis | 1 | 2017 | 13 | 0.560 |
Why?
|
| MAP Kinase Signaling System | 4 | 2013 | 203 | 0.560 |
Why?
|
| Norepinephrine | 1 | 2017 | 98 | 0.550 |
Why?
|
| Genetic Therapy | 2 | 2016 | 733 | 0.540 |
Why?
|
| Chylothorax | 1 | 2016 | 2 | 0.530 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 73 | 0.530 |
Why?
|
| Lipid Droplets | 1 | 2016 | 31 | 0.520 |
Why?
|
| Amines | 1 | 2016 | 29 | 0.510 |
Why?
|
| Multiprotein Complexes | 2 | 2016 | 153 | 0.510 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 31 | 0.500 |
Why?
|
| Cyclic AMP | 3 | 2022 | 142 | 0.490 |
Why?
|
| Extracellular Traps | 1 | 2015 | 41 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2015 | 75 | 0.470 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 50 | 0.470 |
Why?
|
| Diabetes Complications | 1 | 2015 | 100 | 0.470 |
Why?
|
| Gene Deletion | 2 | 2015 | 293 | 0.460 |
Why?
|
| Protein Kinases | 3 | 2014 | 142 | 0.450 |
Why?
|
| 3T3 Cells | 9 | 2009 | 108 | 0.450 |
Why?
|
| Membrane Proteins | 2 | 2016 | 850 | 0.450 |
Why?
|
| Wound Healing | 1 | 2015 | 174 | 0.450 |
Why?
|
| Hepatocytes | 4 | 2022 | 196 | 0.450 |
Why?
|
| Cytokines | 6 | 2017 | 912 | 0.440 |
Why?
|
| Protein Structure, Tertiary | 12 | 2011 | 656 | 0.440 |
Why?
|
| Subcutaneous Fat | 3 | 2021 | 46 | 0.430 |
Why?
|
| Transcription Factors | 4 | 2016 | 1471 | 0.430 |
Why?
|
| CD40 Antigens | 1 | 2013 | 61 | 0.410 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2012 | 6 | 0.410 |
Why?
|
| Palmitates | 2 | 2023 | 21 | 0.410 |
Why?
|
| E-Selectin | 1 | 2012 | 18 | 0.410 |
Why?
|
| Acetyl Coenzyme A | 2 | 2023 | 22 | 0.410 |
Why?
|
| Receptors, Notch | 1 | 2013 | 101 | 0.410 |
Why?
|
| Hypoxia | 2 | 2025 | 112 | 0.400 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 87 | 0.390 |
Why?
|
| Cell Line | 8 | 2018 | 1983 | 0.390 |
Why?
|
| Myoblasts | 1 | 2012 | 63 | 0.390 |
Why?
|
| Glucose Tolerance Test | 4 | 2017 | 96 | 0.380 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 196 | 0.380 |
Why?
|
| Diet | 3 | 2013 | 497 | 0.380 |
Why?
|
| MicroRNAs | 3 | 2011 | 616 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 7 | 2013 | 392 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 527 | 0.370 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 2050 | 0.370 |
Why?
|
| Stem Cells | 3 | 2025 | 255 | 0.370 |
Why?
|
| Phagocytes | 1 | 2011 | 50 | 0.360 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 108 | 0.360 |
Why?
|
| Enzyme Activation | 6 | 2013 | 359 | 0.360 |
Why?
|
| Isoproterenol | 1 | 2010 | 34 | 0.360 |
Why?
|
| COS Cells | 5 | 2011 | 174 | 0.360 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2008 | 51 | 0.350 |
Why?
|
| Body Mass Index | 4 | 2012 | 831 | 0.350 |
Why?
|
| Cell Proliferation | 7 | 2019 | 941 | 0.350 |
Why?
|
| Islets of Langerhans | 3 | 2017 | 271 | 0.350 |
Why?
|
| Omentum | 1 | 2010 | 12 | 0.350 |
Why?
|
| Protein Transport | 8 | 2011 | 399 | 0.340 |
Why?
|
| Models, Biological | 8 | 2009 | 1143 | 0.340 |
Why?
|
| Clathrin | 2 | 2007 | 23 | 0.330 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 1951 | 0.330 |
Why?
|
| Gene Expression | 6 | 2014 | 809 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 619 | 0.330 |
Why?
|
| Blotting, Western | 5 | 2016 | 583 | 0.320 |
Why?
|
| Clonal Anergy | 2 | 2009 | 23 | 0.320 |
Why?
|
| Cell Membrane Structures | 2 | 2008 | 8 | 0.310 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 1206 | 0.300 |
Why?
|
| Flow Cytometry | 3 | 2017 | 645 | 0.290 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 1151 | 0.290 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 9 | 0.290 |
Why?
|
| Neurons | 3 | 2018 | 863 | 0.290 |
Why?
|
| Caspases | 1 | 2009 | 166 | 0.290 |
Why?
|
| Homeostasis | 4 | 2019 | 346 | 0.290 |
Why?
|
| Membrane Fusion | 2 | 2007 | 66 | 0.290 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 192 | 0.280 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 12 | 0.280 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2017 | 10 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 23 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 26 | 0.280 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 1553 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2016 | 411 | 0.280 |
Why?
|
| RNA, Messenger | 9 | 2011 | 1466 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2019 | 294 | 0.280 |
Why?
|
| RNA, Complementary | 2 | 2006 | 18 | 0.270 |
Why?
|
| Phosphatidylinositols | 2 | 2007 | 49 | 0.270 |
Why?
|
| Fatty Acid Synthase, Type I | 2 | 2018 | 5 | 0.270 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 217 | 0.270 |
Why?
|
| Osteoblasts | 2 | 2025 | 195 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 620 | 0.260 |
Why?
|
| Cytoskeleton | 2 | 2004 | 137 | 0.260 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 2 | 0.260 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 4 | 2016 | 20 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 205 | 0.250 |
Why?
|
| Gene Editing | 2 | 2021 | 299 | 0.250 |
Why?
|
| Qb-SNARE Proteins | 1 | 2005 | 3 | 0.250 |
Why?
|
| Oxidative Phosphorylation | 1 | 2005 | 39 | 0.250 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 674 | 0.250 |
Why?
|
| Diabetes Mellitus | 4 | 2021 | 515 | 0.250 |
Why?
|
| Myosin Type I | 4 | 2008 | 7 | 0.240 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 225 | 0.240 |
Why?
|
| Ubiquinone | 1 | 2025 | 17 | 0.240 |
Why?
|
| Fibroblasts | 4 | 2010 | 377 | 0.230 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2004 | 16 | 0.230 |
Why?
|
| Glucose Clamp Technique | 2 | 2016 | 57 | 0.230 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 191 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 38 | 0.230 |
Why?
|
| Epididymis | 2 | 2016 | 26 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 128 | 0.230 |
Why?
|
| Dietary Fats | 3 | 2016 | 173 | 0.230 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2024 | 11 | 0.230 |
Why?
|
| Myogenic Regulatory Factor 5 | 2 | 2015 | 16 | 0.230 |
Why?
|
| Phospholipids | 2 | 2023 | 78 | 0.220 |
Why?
|
| Collagen Type I | 1 | 2024 | 39 | 0.220 |
Why?
|
| Proteoglycans | 2 | 2016 | 31 | 0.220 |
Why?
|
| Hepatic Stellate Cells | 1 | 2024 | 23 | 0.220 |
Why?
|
| Bone and Bones | 1 | 2025 | 137 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 101 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 152 | 0.220 |
Why?
|
| Collagen | 1 | 2024 | 115 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 106 | 0.210 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 384 | 0.210 |
Why?
|
| Fibrosis | 2 | 2021 | 153 | 0.210 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 11 | 0.200 |
Why?
|
| Oxygen | 4 | 2025 | 313 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 210 | 0.200 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2022 | 17 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 163 | 0.200 |
Why?
|
| Substrate Specificity | 5 | 2011 | 333 | 0.190 |
Why?
|
| Lysosomes | 1 | 2023 | 160 | 0.190 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 743 | 0.190 |
Why?
|
| Plasmids | 2 | 2018 | 279 | 0.190 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 289 | 0.190 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2021 | 12 | 0.190 |
Why?
|
| RNAi Therapeutics | 1 | 2021 | 11 | 0.190 |
Why?
|
| Microtubules | 1 | 2003 | 211 | 0.190 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2008 | 142 | 0.190 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 28 | 0.190 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 2021 | 1 | 0.190 |
Why?
|
| Wolman Disease | 1 | 2021 | 1 | 0.190 |
Why?
|
| Exocytosis | 3 | 2007 | 59 | 0.180 |
Why?
|
| Thiazolidinediones | 3 | 2008 | 50 | 0.180 |
Why?
|
| Neuregulins | 1 | 2020 | 8 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2015 | 460 | 0.180 |
Why?
|
| Denervation | 1 | 2020 | 17 | 0.170 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 178 | 0.170 |
Why?
|
| Body Temperature Regulation | 2 | 2018 | 20 | 0.170 |
Why?
|
| Cold Temperature | 1 | 2020 | 51 | 0.170 |
Why?
|
| Time Factors | 7 | 2008 | 3617 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2020 | 110 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2020 | 118 | 0.170 |
Why?
|
| Yeasts | 1 | 2000 | 51 | 0.170 |
Why?
|
| Female | 11 | 2021 | 30726 | 0.170 |
Why?
|
| Peptides | 3 | 2016 | 549 | 0.160 |
Why?
|
| Chemokine CCL2 | 3 | 2017 | 54 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 2000 | 144 | 0.160 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2010 | 40 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 418 | 0.160 |
Why?
|
| Lipopolysaccharides | 4 | 2012 | 627 | 0.160 |
Why?
|
| Coronary Angiography | 1 | 2019 | 176 | 0.160 |
Why?
|
| Hyperglycemia | 2 | 2017 | 98 | 0.150 |
Why?
|
| Trans-Activators | 2 | 2014 | 300 | 0.150 |
Why?
|
| Cell Communication | 1 | 2019 | 124 | 0.150 |
Why?
|
| Middle Aged | 7 | 2019 | 16314 | 0.150 |
Why?
|
| Indoles | 2 | 2009 | 106 | 0.150 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 6 | 0.150 |
Why?
|
| Molecular Biology | 1 | 2019 | 66 | 0.150 |
Why?
|
| Perilipin-1 | 2 | 2008 | 11 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 490 | 0.150 |
Why?
|
| Phenotype | 2 | 2020 | 1137 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2018 | 241 | 0.140 |
Why?
|
| Rats | 5 | 2017 | 1910 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 12 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 91 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 33 | 0.140 |
Why?
|
| Lectins | 1 | 2017 | 40 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 62 | 0.140 |
Why?
|
| Antigen Presentation | 1 | 2019 | 226 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2016 | 50 | 0.140 |
Why?
|
| Proteomics | 2 | 2011 | 263 | 0.140 |
Why?
|
| Electron Transport | 2 | 2025 | 35 | 0.140 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 37 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 111 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 113 | 0.130 |
Why?
|
| Cellular Senescence | 1 | 2017 | 104 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 127 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 190 | 0.130 |
Why?
|
| Sirolimus | 2 | 2008 | 88 | 0.130 |
Why?
|
| Kinetics | 2 | 2009 | 751 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 718 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1091 | 0.130 |
Why?
|
| GTPase-Activating Proteins | 2 | 2008 | 64 | 0.130 |
Why?
|
| Receptors, LDL | 1 | 2015 | 33 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 847 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2025 | 303 | 0.130 |
Why?
|
| Animals, Newborn | 1 | 2016 | 230 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 425 | 0.130 |
Why?
|
| Aminopyridines | 1 | 2015 | 31 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2007 | 164 | 0.120 |
Why?
|
| Cricetinae | 2 | 2008 | 366 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 194 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2015 | 35 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 108 | 0.120 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 81 | 0.120 |
Why?
|
| Citrulline | 1 | 2015 | 44 | 0.120 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2015 | 85 | 0.120 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 155 | 0.120 |
Why?
|
| Transfection | 3 | 2009 | 675 | 0.120 |
Why?
|
| Hydrolases | 1 | 2015 | 81 | 0.120 |
Why?
|
| Isoenzymes | 2 | 2005 | 136 | 0.120 |
Why?
|
| Lipoprotein Lipase | 1 | 2014 | 14 | 0.110 |
Why?
|
| Collagen Type VI | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 66 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 472 | 0.110 |
Why?
|
| Androstadienes | 2 | 2005 | 39 | 0.110 |
Why?
|
| Regeneration | 1 | 2014 | 93 | 0.110 |
Why?
|
| Protein Binding | 3 | 2011 | 1555 | 0.110 |
Why?
|
| Transferrin | 2 | 2004 | 67 | 0.110 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2013 | 3 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 226 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 628 | 0.110 |
Why?
|
| Arachidonic Acids | 1 | 2013 | 23 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2018 | 355 | 0.110 |
Why?
|
| Endocannabinoids | 1 | 2013 | 20 | 0.110 |
Why?
|
| Aging | 1 | 2019 | 710 | 0.110 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 128 | 0.110 |
Why?
|
| Osteogenesis | 2 | 2025 | 140 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 68 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 188 | 0.100 |
Why?
|
| Blood Proteins | 2 | 2010 | 76 | 0.100 |
Why?
|
| Muscle Development | 1 | 2012 | 52 | 0.100 |
Why?
|
| Apoptosis | 3 | 2013 | 1033 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2012 | 51 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 356 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 446 | 0.100 |
Why?
|
| Adrenal Glands | 1 | 2012 | 32 | 0.100 |
Why?
|
| Binding Sites | 4 | 2011 | 881 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 347 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2013 | 260 | 0.090 |
Why?
|
| Immune System | 1 | 2012 | 129 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 13 | 0.090 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 143 | 0.090 |
Why?
|
| Base Sequence | 3 | 2009 | 1302 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 60 | 0.090 |
Why?
|
| Microcirculation | 1 | 2011 | 52 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 81 | 0.090 |
Why?
|
| Adult | 5 | 2016 | 15681 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2011 | 53 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 133 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 60 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 79 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 54 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 481 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2010 | 106 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 439 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 108 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 48 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 80 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 137 | 0.080 |
Why?
|
| Neutrophils | 1 | 2012 | 365 | 0.080 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 29 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 93 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 197 | 0.080 |
Why?
|
| Protein Stability | 1 | 2009 | 85 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2013 | 324 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 1597 | 0.080 |
Why?
|
| Lipodystrophy | 1 | 2009 | 11 | 0.080 |
Why?
|
| Sulfonylurea Compounds | 1 | 2009 | 13 | 0.080 |
Why?
|
| Particle Size | 1 | 2011 | 395 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 679 | 0.080 |
Why?
|
| Ribonuclease III | 2 | 2011 | 82 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 51 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2006 | 83 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2009 | 47 | 0.080 |
Why?
|
| Caspase 6 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Dimerization | 2 | 2006 | 144 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 495 | 0.080 |
Why?
|
| Caspase 8 | 1 | 2009 | 61 | 0.080 |
Why?
|
| Acetamides | 1 | 2008 | 12 | 0.080 |
Why?
|
| Glucans | 1 | 2009 | 63 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2009 | 183 | 0.080 |
Why?
|
| Transport Vesicles | 2 | 2011 | 14 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 127 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 122 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2009 | 103 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 84 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2009 | 164 | 0.080 |
Why?
|
| Aged | 3 | 2019 | 13408 | 0.080 |
Why?
|
| Paxillin | 1 | 2008 | 9 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1119 | 0.080 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2008 | 11 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 56 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 23 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cell Survival | 2 | 2013 | 559 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 179 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 59 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 30 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 148 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2014 | 1925 | 0.070 |
Why?
|
| Deoxyglucose | 2 | 2005 | 31 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 4986 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 689 | 0.070 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 149 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2005 | 295 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 805 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 247 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 540 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 16 | 0.060 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 25 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 13 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2009 | 382 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 21 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2005 | 26 | 0.060 |
Why?
|
| trans-Golgi Network | 1 | 2005 | 7 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 89 | 0.060 |
Why?
|
| Glycolysis | 1 | 2005 | 54 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2007 | 309 | 0.060 |
Why?
|
| Adiponectin | 1 | 2005 | 34 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 841 | 0.060 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2005 | 5 | 0.060 |
Why?
|
| Thymidine | 1 | 2005 | 25 | 0.060 |
Why?
|
| Trypsin | 1 | 2005 | 39 | 0.060 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 15 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 34 | 0.060 |
Why?
|
| Fumarates | 1 | 2025 | 10 | 0.060 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 57 | 0.060 |
Why?
|
| Electrons | 1 | 2025 | 34 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 48 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 178 | 0.060 |
Why?
|
| Phospholipase C delta | 1 | 2004 | 4 | 0.060 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2004 | 7 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 188 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2004 | 63 | 0.060 |
Why?
|
| CD28 Antigens | 1 | 2004 | 60 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 306 | 0.060 |
Why?
|
| Clone Cells | 1 | 2004 | 106 | 0.060 |
Why?
|
| Inositol Phosphates | 1 | 2004 | 18 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2338 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2004 | 27 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 2004 | 2 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 98 | 0.060 |
Why?
|
| Cholesterol | 1 | 2006 | 252 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 33 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2004 | 8 | 0.060 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 7 | 0.060 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2004 | 67 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 70 | 0.060 |
Why?
|
| Ligands | 1 | 2006 | 411 | 0.060 |
Why?
|
| Chromones | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 51 | 0.060 |
Why?
|
| Zinc Fingers | 1 | 2004 | 96 | 0.060 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 34 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 397 | 0.060 |
Why?
|
| CHO Cells | 1 | 2004 | 189 | 0.060 |
Why?
|
| Rhodamines | 1 | 2003 | 20 | 0.060 |
Why?
|
| Morpholines | 1 | 2004 | 86 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 194 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2004 | 122 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2005 | 331 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 365 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 31 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 287 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 50 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 281 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 125 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 196 | 0.050 |
Why?
|
| Thiazoles | 1 | 2003 | 46 | 0.050 |
Why?
|
| Cell Division | 2 | 2014 | 443 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 255 | 0.050 |
Why?
|
| Endosomes | 1 | 2003 | 170 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 623 | 0.050 |
Why?
|
| Organic Anion Transporters | 1 | 2002 | 5 | 0.050 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2002 | 7 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 354 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2002 | 26 | 0.050 |
Why?
|
| Actin-Related Protein 2 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Actin-Related Protein 3 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 7 | 0.050 |
Why?
|
| Oxygen Consumption | 3 | 2008 | 206 | 0.050 |
Why?
|
| Cholesterol Esters | 1 | 2021 | 10 | 0.050 |
Why?
|
| Sterol Esterase | 1 | 2021 | 6 | 0.050 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 19 | 0.050 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 38 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2004 | 608 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 162 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 224 | 0.040 |
Why?
|
| Mutation | 1 | 2008 | 2456 | 0.040 |
Why?
|
| Liver X Receptors | 2 | 2011 | 8 | 0.040 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2011 | 6 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 661 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2011 | 526 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2010 | 6071 | 0.040 |
Why?
|
| Sitagliptin Phosphate | 1 | 2018 | 2 | 0.040 |
Why?
|
| Caveolin 1 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Factor Xa | 1 | 2018 | 5 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 650 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2021 | 256 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 182 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 737 | 0.040 |
Why?
|
| Adipokines | 1 | 2017 | 28 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 39 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2017 | 7 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 39 | 0.030 |
Why?
|
| Glycine | 2 | 2008 | 46 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 88 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 4 | 0.030 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2016 | 7 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 90 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2017 | 173 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5119 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2007 | 424 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1368 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 3 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 648 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 34 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 587 | 0.030 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2013 | 5 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 170 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2012 | 107 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 48 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 345 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 250 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 21 | 0.020 |
Why?
|
| Thioglycolates | 1 | 2011 | 7 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 66 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 30 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 16 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 36 | 0.020 |
Why?
|
| Peritonitis | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 92 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 78 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 368 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2011 | 74 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 301 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 82 | 0.020 |
Why?
|
| Columbidae | 1 | 2009 | 11 | 0.020 |
Why?
|
| Leukemia | 1 | 2009 | 57 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 26 | 0.020 |
Why?
|
| Pedigree | 1 | 2009 | 183 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 426 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2009 | 65 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2009 | 56 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Carcinoma | 1 | 2009 | 116 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 289 | 0.020 |
Why?
|
| Antigens | 1 | 2009 | 146 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1307 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 130 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2009 | 192 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 555 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 135 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2008 | 31 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 45 | 0.020 |
Why?
|
| Longevity | 1 | 2009 | 110 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2008 | 103 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 188 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 868 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1504 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 428 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 574 | 0.020 |
Why?
|
| Crystallization | 1 | 2005 | 97 | 0.020 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2005 | 3 | 0.020 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2005 | 8 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2005 | 20 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 3067 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 40 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 44 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 40 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 2004 | 13 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 63 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 38 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 248 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1128 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 5838 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4272 | 0.010 |
Why?
|